← Back to Clinical Trials
Recruiting NCT06093022
Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study
Trial Parameters
Condition Breast Cancer
Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Type OBSERVATIONAL
Phase N/A
Enrollment 720
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2018-04-01
Completion 2024-10-31
All Conditions
Brief Summary
The liver represents the third most common site of breast cancer (BC) metastases behind the lymphatics and bone. The primary treatment for BCLM remains chemo-therapy and, more recently, targeted immunotherapy. The role of liver resection in BCLM remains controversial. The primary aim of the study is to compare the efficacy of liver resection vs. medical therapy alone in Breast Cancer Liver Metastasis (BCLM) patients.
Eligibility Criteria
Inclusion Criteria: * \> 18 years old * BCLM * BCLM and extra-hepatic disease * Any treatment * Ability to understand and sign the informed consent Exclusion Criteria: * Inability to provide the informed consent * Patient who underwent Best Supportive Care or Palliation
Related Trials
NCT05573893
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Rea
View Trial →
NCT04965064
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Br
View Trial →
NCT03449264
Development of Clinical and Biological Database
View Trial →